In vitro and ex vivo measurement of the biophysical properties of blood using microfluidic platforms and animal models
文献信息
Yang Jun Kang, Sang-Joon Lee
Haemorheologically impaired microcirculation, such as blood clotting or abnormal blood flow, causes interrupted blood flows in vascular networks. The biophysical properties of blood, including blood viscosity, blood viscoelasticity, haematocrit, red blood bell (RBC) aggregation, erythrocyte sedimentation rate and RBC deformability, have been used to monitor haematological diseases. In this review, we summarise several techniques for measuring haemorheological properties, such as blood viscosity, RBC deformability and RBC aggregation, using in vitro microfluidic platforms. Several methodologies for the measurement of haemorheological properties with the assistance of an extracorporeal rat bypass loop are also presented. We briefly discuss several emerging technologies for continuous, long-term, multiple measurements of haemorheological properties under in vitro or ex vivo conditions.
相关文献
Adiabatic and non-adiabatic corrections to rovibrational energies of diatomic molecules: variational calculations with experimental accuracy
DOI: 10.1039/B700044H
Consequences of chain networks on thermodynamic, dielectric and structural properties for liquid water
Steven W. Rick
DOI: 10.1039/B614742A
Fluorescence quenching in cyclic hydrogen-bonded complexes of 1H-pyrrolo[3,2-h]quinoline with methanol: cluster size effect
Alexander Kyrychenko, Randolph P. Thummel, Jacek Waluk, Bernhard Brutschy, Jerzy Herbich
DOI: 10.1039/B703908E
The dynamics of water exchange in gadolinium DOTA complexes studied by transition path sampling and potential of mean force methods
DOI: 10.1039/B617068D
Fourier transform infrared spectroscopy and ab initio theory of acid–hydrogen sulfide clusters: H2S–HCl, D2S–DCl and H2S–(HCl)2
Pierre Asselin, Pascale Soulard, Bruno Madebène, Marius Lewerenz
DOI: 10.1039/B702824E
Can “microwave effects” be explained by enhanced diffusion?
Christian Antonio, Rowan T. Deam
DOI: 10.1039/B617358F
Computational assessment of the entropy of solvation of small-sized hydrophobic entities‡
Dieter Kranzlmüller, Jens Volkert, Siegfried Höfinger
DOI: 10.1039/B611200E
Controlling crystallization and its absence: proteins, colloids and patchy models
Jonathan P. K. Doye, Ard A. Louis, I-Chun Lin, Lucy R. Allen, Eva G. Noya, Alex W. Wilber, Hoong Chwan Kok, Rosie Lyus
DOI: 10.1039/B614955C
您可能还喜欢
(5-氨基吡唑-3-基)乙酸(CAS号:174891-10-2)的物理化学性质是什么?
(5-氨基吡唑-3-基)乙酸是一种无色至白色固体,分子量为174.15 g/mol。它在水中具有较好的溶解性,在有机溶剂中的溶解度较低。该化合物具有较好的反应活...
3-氟-4,5-二氯苯胺(CAS号:35754-38-2)适用哪些法规指南?
3-氟-4,5-二氯苯胺受到多项法规指南的约束,包括但不限于GHS(全球化学品统一分类和标签制度)的危险分类标准、欧盟的REACH法规(注册、评估、授权和限制)...
什么是(R)-(+)-2,2',6,6'-四甲氧基-4,4'-联(二(3,5-二甲苯基基)膦基)-3,3'-二联吡啶(CAS号:442905-33-1)?
这是一种有机化合物,化学名为(R)-(+)-2,2',6,6'-四甲氧基-4,4'-联(二(3,5-二甲苯基基)膦基)-3,3'-二联吡啶,CAS号为44290...
1-氨基-2-氰基萘(CAS号:3100-67-2)应用于哪些行业?
1-氨基-2-氰基萘在医药、聚合物、传感器和半导体等行业中有应用。在医药领域,它可用作中间体合成某些药物。在聚合物行业,它可以用于制备具有特定性能的聚合物。此外...
如何处理含有1-溴-4-(异丙氧基甲基)苯(CAS号:98446-84-5)的废料?
处理含1-溴-4-(异丙氧基甲基)苯的废料时,首先应确保废液收集在防渗漏的容器中,避免泄露。然后,可以考虑采用化学降解法或物理吸附法进行处理。在特定条件下,可通...
6-Chloro-8-(trifluoromethyl)chroman-4-one(CAS号:1344889-75-3)的主要用途是什么?
6-氯-8-三氟甲基-2,3-二氢-4H-色喃-4-酮主要用于有机合成中的中间体,也可作为研究试剂使用。
7-乙氧基-2-萘酚(CAS号:57944-44-2)通常如何合成?
7-乙氧基-2-萘酚通常通过N-乙氧基化反应合成,首先将2-萘酚与乙醇钠在乙醇中反应生成7-乙氧基-2-萘酚钠盐,再通过酸化进一步得到7-乙氧基-2-萘酚。该合...
4-(1,1-二氧硫代吗啉)丁醇(CAS号:59801-41-1)适用哪些法规指南?
该化合物需遵循一系列的法规指南,包括但不限于GHS全球统一分类和标签制度,其分类可能包括易燃液体和可能危害水生环境。在欧洲,还需遵循REACH法规,确保物质和混...
4-甲氧基苄基叠氮甲酸酯(CAS号:25474-85-5)的物理化学性质是什么?
4-甲氧基苄基叠氮甲酸酯是一种无色液体,具有一定的挥发性。其分子量为198.16,熔点为-69°C,沸点为105°C。该化合物在水中溶解度较低,在有机溶剂如乙醇...
如何处理含有4-氯-2-氟嘧啶(CAS号:51422-00-5)的废料?
含有4-氯-2-氟嘧啶的废料应按照危险废物处理。首先,应收集并分类这些废料,避免与其他废物混合。然后,可以采用焚烧处理或者交由专业机构进行处置。在处理过程中,需...
来源期刊
Analyst

Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.











![N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-L-methionylglycine structure N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-L-methionylglycine structure](https://cnstatic.chemtradehub.com/structs/234/23446-03-9-e1e5.webp)

![1-oxaspiro[4.4]nonan-6-one structure 1-oxaspiro[4.4]nonan-6-one structure](https://cnstatic.chemtradehub.com/structs/134/134179-01-4-e051.webp)
